If Ozempic Makes People Eat Less, Maker of Cheez-It Will Be Ready

Pfizer and GSK’s New RSV Vaccines On Track For $2 Billion in Sales

The Secret Plot Against the Head of the World Health Organization

Traders Win Reprieve After ‘Political Circus’ of Shutdown Fight

DEA Loosens ADHD Drug Production Controls Amid Shortage

Weight-Loss Drugmaker Carmot Therapeutics Is Considering IPO

Here’s What Stops — And What Doesn’t — If the US Government Shuts Down

Weight-Loss Drugs Pose Risks for People Over 65, Experts Say

US Government Shutdown’s Economic Risks Grow the Longer It Lasts

Investors With $24 Trillion Push Companies to Curb Nature Impact

Eisai’s Alzheimer’s Drug Wins Approval in Japan, Following US

Russia May Be About to Get a New Friendly Leader in Europe